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ABSTRACT: Sixteen captive female red deer were successfully anesthetized to surgically implant a
telemetry system. The deer were immobilized with (mean6SD) 1.7960.29 mg/kg xylazine and
1.7960.29 mg/kg tiletamine/zolazepam given intramuscularly with a dart gun. Anesthesia was
maintained for 6962 min using a total intravenous protocol with a catheter placed in the jugular
vein. Group X received xylazine (0.560.055 mg/kg/hr) and group D, detomidine (260.22 mg/kg/
hr), both in combination with ketamine (260.02 mg/kg/hr) and midazolam (0.0360.0033 mg/kg/
hr), as a constant rate infusion. Anesthesia was reversed with 0.0960.01 mg/kg atipamezole and
8.761.21 mg/kg sarmazenil given intravenously in both groups. These drug combinations provided
smooth induction, stable anesthesia for surgery, and rapid recovery. Respiratory depression and
mild hypoxemia were seen, and we, therefore, recommend using supplemental intranasal oxygen.
Key words: Detomidine, ketamine, midazolam, red deer, total intravenous anesthesia,
xylazine.
INTRODUCTION
Approximately five million deer live in
captivity worldwide and interest in farmed
deer is growing exponentially (Hudson,
2001). Procedures such as hoof care,
treatment of dystocia or amputation of
antlers are commonly performed in deer,
and an in-depth knowledge about immo-
bilization and anesthesia is necessary.
Many sedative and anesthetic protocols
have been evaluated in various deer
species during the past two decades.
Numerous reports describe the use of
injectable anesthetics alone or in combi-
nation with local anesthesia for short
surgical procedures. Potent opioids or
cyclohexamines (tiletamine, ketamine) in
combination with benzodiazepines or al-
pha-2 adrenoceptor agonists are common-
ly used for immobilization and short-term
anesthesia in red deer (McKelvey and
Simpson, 1985; Caulkett, 1997; Janovsky
et al., 2000). For prolonged or invasive
procedures, inhalation anesthesia is rec-
ommended (Caulkett, 1997). As inhalation
anesthesia can be difficult to perform
under field conditions, a safe protocol
using total intravenous anesthesia (TIVA)
would be valuable.
The aims of this study were to evaluate
a TIVA protocol using a combination of
midazolam, ketamine, and xylazine or
detomidine to maintain anesthesia in red
deer and to investigate the effects of
partial antagonization of this combination
with atipamezole and sarmazenil.
MATERIALS AND METHODS
Animals
Sixteen female free-ranging red deer (Cer-
vus elaphus hippelaphus), living in a 45-ha,
forested portion of the Research Institute
of Wildlife Ecology in Vienna, Austria
(48u12900N, 16u22900E), were immobilized.
Animals had a mean6SD age of 4.161.3 yr
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(range,1.5–6 yr) and a body weight of
120615 kg (range, 90–135 kg). Body weight
was estimated by one person before darting;
after induction, the exact weight was deter-
mined by weighing with an electronic balance.
Surgery was performed to implant a self-
constructed telemetry system as part of an
etho-ecologic project. A ventral midline neck
incision was made through the skin, and the
subcutaneous tissue was separated by blunt
dissection to form a pouch on the left ventro-
lateral aspect of the neck. Two incisions were
made along the caudal ventral midline of the
pouch for placement of the electrocardiogram
(ECG) electrodes. Electrodes were pulled
from the transmitter pouch through a subcu-
taneous tunnel prepared with a sterile cathe-
ter. The transmitter and electrodes were fixed
to the subcutis, and the skin incisions were
closed with absorbable suture material (Gia-
cometti et al., 2001). This study was approved
by the Institutional Ethics Committee of
the Veterinary University of Vienna and
had governmental approval (reference, GZ
68.205/88-BvGt/2002).
Study design
A parallel study design was used, and
animals were randomly divided into two
groups. Group X received a TIVA protocol
using midazolam, ketamine, and xylazine given
as a continuous rate infusion (CRI) after initial
immobilization with tiletamine, zolazepam,
and xylazine. In group D, anesthesia was
maintained using a CRI with midazolam,
ketamine, and detomidine.
Anesthesia
Two days before surgery the deer were
brought into a 1-ha, restricted area. Food, but
not water, was withheld for 24 hr. Lyophilized
powder of 500 mg tiletamine-zolazepam (Zo-
letil, Virbac, Carros, France) and 500 mg of
lyophilized xylazine powder (Rompun TS,
Bayer, Leverkusen, Germany) were dissolved
in 5 ml water for injection. This resulted in a
concentration of 50 mg tiletamine, 50 mg
zolazepam, and 100 mg xylazine per milliliter
of solution. The body weight of the animal was
estimated, and a 3-ml, plastic dart (Telinject
G.U.T., Roemerberg, Germany) was prepared.
The animal was darted with 2 to 2.5 ml of the
solution intramuscularly in the upper hind leg
or shoulder area using a CO2-pressurized dart
gun (Daninject, Selerup, Denmark). Time (in
minutes) from darting to initial effect with
head on the ground (onset time) was recorded.
Thereafter, the animals were transported from
the enclosure to the operating theater (dis-
tance, approximately 600 m), where endotra-
cheal intubation was performed. Time from
darting to intubation (intubation time) was
recorded.
A catheter (Intraflon2, 12 G, Vycon,
Ecoune, France) was placed in the left jugular
vein for intravenous (IV) administration of
10 ml/kg/hr lactated Ringer’s solution (Ringer
Lactat ‘‘Fresenius,’’ Fresenius Kabi Austria
GmbH, Graz, Austria) and anesthesia mainte-
nance using CRI. After endotracheal intuba-
tion, the tube was connected to a circle system
delivering an oxygen/air mixture with an
inspiratory oxygen concentration (FIO2) of
30–50%. Animals breathed spontaneously.
The animals were positioned in right lateral
recumbency with the left foreleg pulled
forward.
To prepare the CRI solution, 250 mg
xylazine (Xylasol, Dr. E. Gra¨ub AG, Berne,
Switzerland) for group X, or 1.4 mg detomi-
dine (Domosedan, Pfizer, Vienna, Austria) for
group D, plus the 1,000 mg ketamine (10%
Narketan, Vetoquinol Austria GmbH, Vienna,
Austria) and 15 mg midazolam (Midazolam
Mayrhofer Pharmazeutika, Vienna, Austria)
were mixed in 500 ml saline (0.9% NaCl
‘‘Fresenius,’’ Fresenius Kabi). This resulted in
a concentration of 0.5 mg/ml xylazine or 2.0 mg/
ml detomidine, 2 mg/ml ketamine, and
0.03 mg/ml midazolam. For the first 20 min,
an infusion rate of 1.2 ml/kg/hr was adminis-
tered via an infusion pump (AsenaTM, Alaris
Medical UK Ltd, Basingstoke, Hampshire,
UK). Thereafter, CRI rate was reduced
stepwise in 10% increments every 10 min.
The duration of CRI administration and the
total volume given were noted.
After surgery, the animals were brought back
to the restricted area. Twenty minutes after the
end of anesthesia, a combination of 10 mg
atipamezole (Antisedan, Pfizer) and 1 mg sar-
mazenil (Sarmasol, Dr. E. Gra¨ub AG, Bern,
Switzerland) was administered by IV. The
catheter and endotracheal tube were removed.
Time from administration of the antagonists to
sternal recumbency (sternal time) and standing
(up time) were recorded. Quality of recovery
was evaluated as excellent (standing on first
attempt, normal gait without ataxia), good
(standing on first attempt with minimal ataxia,
moving with unsteady gait) or poor (requiring
more than one attempt to standing, moderate to
severe ataxia, and falling over). Animals were
observed for 4 hr after surgery.
Monitoring
A catheter (Vasocan Braunu¨le, 0.9 3 25 mm,
B. Braun, Melsungen, Germany) was placed in
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the auricular artery for invasive measurement
of arterial blood pressure (Combitrans Mon-
itoring-Set Arteriell, Fa., Braun). The blood
pressure transducer was positioned and cali-
brated to atmospheric pressure at the level of
the sternum. An arterial blood sample for
blood gas analysis was taken in four deer in
each group before the endotracheal tube was
connected to the circle system and 20 and
40 min after connection to the circle system.
The blood samples were analyzed immediately
after sampling using a portable blood gas
analyzer (I-STAT Portable Clinical Analyzer;
I-STAT Corporation, East Windsor, New
Jersey, USA). An oxygen partial pressure
(PaO2) of lower than 60 mmHg (8 kPa) at the
second blood gas analysis was seen as the
cutoff point to increase FIO2 from 30% to 50%
to 100%. Heart rate (HR) was determined
from the ECG in a base-apex lead (HP CMS
Monitor M1001A, Hewlett Packard, Boeblin-
gen, Germany). Respiratory rate (RR) and
end-tidal carbon dioxide tension (PECO2) were
evaluated using a side stream capnograph
(Nellcor, Hayward, California, USA). The
same device was used to evaluate hemoglobin
oxygen saturation (SpO2) by placing the probe
of the pulse oximeter on the tongue. Tidal
volume (VT) was measured using a Wright
spirometer (Dra¨ger, Lu¨beck, Germany), posi-
tioned in the expiratory limb of the circle
system. For measuring core body temperature
(T), an esophageal temperature probe was
used (HPM1008P, HP CMS Monitor, Hewlett
Packard). All parameters were manually re-
corded at 10-min intervals. Any side effects
throughout the time under anesthesia were
recorded.
Statistical analyses
Results are expressed as mean6SD. Differ-
ences in HR, RR, PECO2, and T between the
two groups were analyzed using an unpaired
Student’s t-test for normally distributed data
and the Wilcoxon rank-sum test for nonpara-
metric data. One-way analysis of variance
(ANOVA) was used to compare repeatedly
measured parameters within a group. Statisti-
cal significance was determined at P,0.05.
RESULTS
The mean dose for initial immobiliza-
tion with xylazine and tiletamine/zola-
zepam was 1.7960.29 mg/kg and
1.7960.29 mg/kg, respectively. Onset
time, intubation time, and duration of
CRI were 8.263.6 min, 30619 min, and
6962 min, respectively. Mean infusion
rate was 160.1 ml/kg/hr with a total
volume of 138618.9 ml. Mean dose of
xylazine and detomidine was 0.546
0.03 mg/kg/hr and 1.5560.6 mcg/kg/hr,
respectively, and was 2.160.2 mg/kg/hr
for ketamine and 3.260.4 mg/kg/hr for
midazolam. There were no significant
differences between groups. Total time
of anesthesia from darting to end of
recovery period was 116615 min.
Heart rate, mean blood pressure, RR,
and PECO2 were higher in group X than
group D, but this was not statistically
significant. Tidal volume was significantly
lower in group X at time points 25, 35, 45,
55, and 65 min (Table 1). Depth of
anesthesia was easy to adapt in both
groups.
Results of blood gas analyses are
summarized in Table 2. Both groups
showed hypercapnia, respiratory acidosis,
and decreased PaO2. No significant differ-
ences were seen for PaO2 between groups.
Mean PaO2 before oxygen supplementa-
tion was 82619.7 mmHg (10.862.6 kPa)
and, after connection to the anesthetic
circle system, was 105618.5 mmHg
(1462.4 kPa). In both groups, PaO2
increased significantly over time. The
partial pressure of carbon dioxide (PaCO2)
was significantly higher at all time points
in group X (P,0.001) than in group D.
The mean doses of sarmazenil and
atipamezole were 8.761.2 mg/kg and
0.0960.01 mg/kg, respectively. Times to
reach sternal recumbency and to standing
after antagonization were 0.960.6 min
and 1.961.6 min, respectively. Mean
duration of recovery was 21.762.6 min.
No differences were seen between groups.
Quality of recovery was excellent in 15
deer. One deer in group X received no
reversal because it recovered spontane-
ously 14 min after the end of anesthesia.
Another deer in group X became recum-
bent again 20 min after reversal and,
therefore, received an additional bolus of
10 mg atipamezole and 1 mg sarmazenil
IV. Heart rates recorded from the telem-
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etry systems varied from 44620 to 77623
in the first 24 hr after end of anesthesia,
and no significant differences were seen
between the two groups.
DISCUSSION
Inhalation anesthesia is recommended
for prolonged or invasive procedures in
cervids (Caulkett, 1997). Expensive and
bulky equipment is necessary to main-
tain inhalation anesthesia under field
conditions. The TIVA protocol used in
our deer provided a good level of anes-
thesia for a surgical procedure lasting
longer than 1 hr and can easily be applied
under field conditions. The major side
effect seen in this study was respiratory
depression causing hypercapnia and mild
hypoxemia. Therefore, oxygen supplemen-
tation is highly recommended. Nasal
insufflation of oxygen at 10 l/min has been
proven to reduce hypoxemia under field
conditions (Read et al., 2001, Mich et al.,
2008).
Blood gas analyses revealed hypercap-
nia, respiratory acidosis, and decreased
PaO2 in both groups. However, higher
TABLE 1. Physiologic variables of red deer maintained anesthetized with a continuous rate infusion of
midazolam, ketamine and xylazine or detomidine. Numbers are mean6SD.
Variablea
Time (min)
5 15 25 35 45 55 65
HR X (beats/min) 50615 4465.5 4665.9 4866.8 5068.2 4763.9 4566.7
HR D (Beats/min) 4365.2 4263.9 4466.1 4468.3 46611 45612 47615
SAP X (mmHg) 104613.8 109615.8 107614.9 10612.8 104613.5 101614.1 97615.5
SAP D (mmHg) 117612.8 115615.6 113617.1 108621.1 113618.6 113619.5 111619.6
RR X (breaths/min) 23613.4 28611.9 32610.8 3169.8 28610.9 26611.5 22610.9
RR D (breaths/min) 18615.6 17612.6 19614.9 19612.1 22613.4 21610.7 1868.7
PECO2 X
mmHg 63614.6 6368.7 65613.1 6569.4 70610.5 7269.6 80615.9
kPa 8.4 61.9 8.461.2 8.661.7 8.661.3 9.361.4 9.661.3 10.66 2.1
PECO2 D
mmHg 55615.4 59614.3 6368.7 6369.9 61615.5 6669.1 6569.3
kPa 7.362.1 7.861.9 8.461.2 8.461.3 8.162.1 8.861.2 8.661.2
VT X (ml/breath) 450694 5136155 469665* 506690* 494677* 4576109* 383676*
VT D (ml/breath) 5866237 6696188 6816171 7316148 6886168 6956130 728686
T X (C) 3860.6 3860.5 3960.5 3960.5 3860.5 3960.4 3960.5
T D (C) 3861.1 3960.9 3960.7 3960.7 3960.7 3960.7 3960.5
* Significant difference (P,0.001) between xylazine and detomidine.
a X 5 xylazine; D 5 detomidine; HR 5 heart rate; SAP 5 systolic arterial blood pressure; RR 5 respiratory rate; PECO2 5
end expiratory carbon dioxide; VT 5 tidal volume; T 5 temperature.
TABLE 2. Blood gas values of four red deer in group xylazine and four in group detomidine that were
maintained anesthetized with a continuous rate infusion of midazolam, ketamine, and xylazine or detomidine.a
Group Sampling interval PaO2 (mmHg) PaCO2 (mmHg) Base excess HCO3 pH Lactate
Xylazine
(n54)
1 82.7619.7 75.166.8* 463.4 3263.4 7.260.1 0.960.4
2 88.564.5 79.1611.2* 4.563 3263.5 7.260.1 160.6
3 105.5618.2 76.3612.2* 3.861.3 3261.2 7.260.1 0.760.3
Detomidine
(n54)
1 58.2611.8 59.469.3 3.163.2 29.663.4 7.360.1 1.661.4
2 79.5617.9 6769.6 5.462.4 31.563.3 7.360.1 1.360.9
3 107.7667.6 67.968.5 6.162.7 31.864 7.360.1 0.860.5
* Significant differences (P,0.001) between xylazine and detomidine.
a PaO2 5 oxygen partial pressure; PaCO2 5 partial pressure of carbon dioxide; HCO3 5 bicarbonate.
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PaCO2 and PECO2 levels were seen in the
xylazine group. This indicates that the
combination that included xylazine caused
more respiratory depression than the
detomidine combination did. Along with
the higher CO2 levels, higher PaO2 levels
were seen in the xylazine group. Similar
findings were reported with a xylazine-
tiletamine-zolazepam mixture in wapiti
(Cervus canadensis; Read et al., 2001).
The most likely explanation for this finding
is a higher ventilation/perfusion mismatch
and intrapulmonary shunt volume in
group D leading to lower PaO2 values
compared with those for group X. How-
ever, because Pa/PaO2 differences were
not evaluated because the inspiratory
oxygen concentration was not measured,
this remains an assumption. Ventilation/
perfusion mismatch and intrapulmonary
shunt volume are not directly correlated to
pulmonary ventilation, which was better
maintained in group D, resulting in lower
PaCO2 levels.
Combinations of tiletamine-zolazepam
and xylazine and prolongation of anesthe-
sia with ketamine are widely used for the
immobilization of cervids (Caulkett, 1997;
Galka et al., 1999; Fernandez-Moran et
al., 2000; Janovsky et al., 2000; Read et al.,
2001). These combinations can lead to
prolonged recovery because of the accu-
mulation of ketamine and norketamine, its
first metabolite. An overhang with keta-
mine or norketamine can lead to increased
muscle tone and increased oxygen con-
sumption during recovery. Therefore,
alternative protocols, combining ketamine
with muscle relaxants and sedatives, could
be useful because the ketamine dose can
be reduced. A TIVA protocol, including
guaifenesin, can be used in cattle and
small ruminants, but cervids seem to be
particularly sensitive to toxic side effects of
guaifenesin, including extensor rigidity
and opisthotonus (Lin et al., 1993; Rie-
bold, 1996; Caulkett, 1997). The adminis-
tration of the benzodiazepine midazolam
for central muscle relaxation, instead of
guaifenesin, is a relatively new technique.
Unlike diazepam, midazolam is water
soluble and can, therefore, be mixed with
other drugs in a CRI solution. The use of
midazolam in combination with ketamine
for induction in wild ruminants is limited
to one case report in a buffalo (Syncerus
caffer; Stegmann, 2004). Midazolam, ke-
tamine, and three different alpha-2 adre-
noceptor agonists (xylazine, detomidine,
and medetomidine) in combination with a
low dose of isoflurane was used for
maintenance in horses (Equus caballus;
Mosing et al., 2007). Xylazine and deto-
midine were preferred over medetomi-
dine as the former two alpha-2 adreno-
ceptor agonists are licensed for ruminants
in the European Union (European Com-
mission, 2009). This is an important issue
in the case of deer farmed for meat
production within the European Union.
Using medetomidine as part of the main-
tenance protocol, instead of xylazine or
detomidine, for wildlife captures (in which
case, the cascade must not be considered)
might result in quicker onset times, less
stressful responses, more cardiovascular
stability, and quicker recovery when using
atipamezole (Jalanka and Roeken, 1990;
Caulkett et al., 2000; Ferna´ndez-Mora´n et
al. 2000; Mich et al., 2008)
When continuous-rate infusions are
used to provide long-term anesthesia,
drugs with a short-elimination half-life
are preferable to avoid accumulation.
Midazolam has a relatively short elimina-
tion half-life, which makes it a valuable
drug that can be given via CRI (Hall et al.,
1988; Fragen, 1997). As already men-
tioned, the limitation of the benzodiaze-
pine-ketamine CRI is the ketamine com-
ponent. Pharmacokinetic studies done in
horses revealed no cumulative effect after
administration of ketamine CRI lasting
60 min. Norketamine, the active metabo-
lite of ketamine was detected throughout
the study period. Recovery was smooth in
all animals (Nolan et al., 1996). In another
study, two of six ponies showed some
excitement and ataxia after 120 min of
ketamine-climazolam CRI (Bettschart-
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Wolfensberger et al., 1996). The reason
for these poor-quality recoveries is dis-
cussed as being an accumulation of
norketamine. However, no ketamine-asso-
ciated side effects were noted during
recovery for our red deer. The antagonists
were given only 20 min after termination
of ketamine infusion in our red deer, and
this might have reduced possible halluci-
nogenic side effects of ketamine.
Regurgitation and aspiration can occur
when protective airway reflexes are abol-
ished in ruminants. This is an important
factor because cervids are difficult to
intubate, compared with small animals
and horses. Protective reflexes are mostly
maintained with ketamine and are abol-
ished under inhalation anesthesia. No
regurgitation was observed in this study
using midazolam, ketamine and xylazine,
or detomidine anesthesia. We would still
recommend intubating deer for prolonged
procedures, even under field conditions,
to maintain airway patency and avoid
aspiration.
Side effects of xylazine described in
cervids, besides respiratory and cardiovas-
cular depression, include ruminal tympa-
ny, regurgitation, and decreased thermo-
regulation ability (Caulkett, 1997). In
wapiti, dose recommendations for xylazine
are 1 mg/kg. For white-tailed deer (Odo-
coileus virginianus) and mule deer (Odo-
coileus hemionus) higher doses (2 mg/kg)
are recommended (Caulkett, 1997). The
xylazine dose used in our study falls within
this range. No regurgitation or tympany
was observed.
Prolonged recoveries might lead to
decreased survival of deer in the wild.
Free-ranging animals have to respond
quickly to dangerous environmental situ-
ations. For this reason, reversible proto-
cols are preferred for immobilization of
wildlife. In this study, a mixture of
atipamezole and sarmazenil IV was used
for antagonization. Atipamezole is the
most potent and selective alpha-2 adreno-
ceptor antagonist, and is primarily used for
the reversal of medetomidine. Its use, to
antagonize detomidine after continuous
rate infusion of up to 110 min, has been
evaluated in horses (van Dijk et al., 2003).
After atipamezole, all horses could walk
without ataxia, and no relapse into seda-
tion occurred for 1 hr after antagonization.
Atipamezole is also recommended in deer
after the use of detomidine (Hall et al.,
2001). In our study, no deer in group D
showed excitement or relapse into seda-
tion during the observation period.
The effectiveness of atipamezole to
antagonize xylazine has been shown in
white-tailed deer, Arabian oryx (Oryx
leucoryx), grey duikers (Sylvicapra grim-
mia), and axis deer (Axis axis; Arnemo et
al., 1993; Ancrenaz, 1994; Nicholls et al.,
1996; Miller et al., 2004). Reversal was not
constant in all species, and some animals
showed incomplete reversal or resedation
after 2 to 5 hr (Ancrenaz, 1994; Nicholls et
al., 1996; Miller et al., 2004). On the other
hand, one of eight axis deer sedated with
xylazine alone showed signs of overalert-
ness after reversal with atipamezole IV,
and no cases of resedation were observed
(Arnemo et al., 1993). One animal from
group X showed resedation 20 min after
reversal, and an additional bolus of
atipamezole and sarmazenil had to be
given by IV.
Sarmazenil is a partial inverse benzodi-
azepine receptor agonist and was used to
antagonize the effects of midazolam.
Benzodiazepines bind to a specific benzo-
diazepine receptor site on c-aminobutyric
acid A receptors (GABAA) in the brain.
Genuine antagonists, like flumazenil, bind
to the same site as benzodiazepines,
without affecting the GABA-binding.
Therefore, the only pharmacological effect
is that benzodiazepine agonists are dis-
placed from the receptor site. Flumazenil
has been used in many species in veter-
inary anesthesia. One report in white-
tailed deer did not affect recovery time
(Miller et al., 2004). Sarmazenil, on the
other hand, interacts with the benzodiaz-
epine binding site on the receptor and
reduces GABA binding and GABA-in-
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duced chloride flux (Haefely, 1983). Sar-
mazenil is the specific antagonist of
climazolam and is mainly used in horses
(Bettschart-Wolfensberger et al., 1996).
Both sarmazenil and flumazenil have
stimulatory effects on locomotion and on
exploratory behavior in mice (Mus mus-
culus) and therefore might reverse the
sedative effect of other drugs as well
(Jackson and Nutt, 1992). In our study,
sarmazenil, given together with atipame-
zole, provided rapid and complete reversal
without causing excitation or obvious
hypermotility.
In conclusion, we describe two feasible
TIVA protocols for red deer to perform
prolonged procedures under field condi-
tions. No adverse effects like tympany or
regurgitation were observed in any of the
16 deer. However, the supplementation of
oxygen was crucial to avoid hypoxemia.
Reversal of anesthesia was rapid, smooth,
and complete using a combination of
atipamezole and sarmazenil IV.
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